Hrt Financial »

Xilio Therapeutics shares owned by Hrt Financial

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $20k 25k 0.81

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Apple Put
Ishares Tr Russell 2000 Etf (IWM)
Nvidia Corporation Put
Microsoft Corporation (MSFT)
Microsoft Corp Put
Johnson & Johnson (JNJ)
Amphenol Corp Cl A (APH)
Applovin Corp Call
Grab Holdings Class A Ord (GRAB)
Apple Call
Tesla Motors (TSLA)

View all positions for Hrt Financial

Top funds holding Xilio Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Merck & Co
Takeda Pharmaceutical
Morgan Stanley
Vanguard Group
AJU IB Investment
FMR
Geode Capital Management
Squarepoint Ops
Trustees of Columbia University in the City of New York
Renaissance Technologies
Balyasny Asset Management
State Street Corporation
Two Sigma Investments

View all funds holding Xilio Therapeutics